García-Talavera P, Díaz-Soto G, Montes A A, Villanueva J G, Cobo A, Gamazo C, Ruiz M Á, González-Selma M L
Servicio de Medicina Nuclear, Hospital Clínico Universitario de Salamanca, Salamanca, Spain.
Servicio de Endocrinología, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Rev Esp Med Nucl Imagen Mol. 2016 Nov-Dec;35(6):351-357. doi: 10.1016/j.remn.2016.03.001. Epub 2016 May 4.
To evaluate the value of Tc-MIBI double-phase scintigraphy (DPS) and early SPECT/CT in the pre-surgical assessment of patients with primary hyperparathyroidism (PHPT). Also, to calculate the correlation between uptake and some biological parameters.
Forty patients with PHPT were included: 37 solitary adenomas, 1 hyperplasia, and 2 double adenomas. Fifteen patients had ectopic glands. DPS and early SPECT/CT were acquired in all patients. Ultrasound was performed in 31/40. All patients underwent surgery, intra-operative iPTH measurements, and histopathological examinations. Qualitative DPS uptake was assessed and correlated to pre-surgical calcium, iPTH levels, gland weight, and maximum diameter.
In the planar study, there were 23 positive cases, 8 doubtful, and 9 negatives. With the SPECT/CT, 8/9 negatives cases were located. All doubtful cases were confirmed as positives. Gland location improved in 16 cases (12 ectopic). DPS+SPECT/CT failed to detect a solitary adenoma and at least one gland in three cases of multiglandular disease (MGD). The sensitivity by patient was: DPS 72.5%, DPS+SPECT/CT 90%, and ultrasound 42%. Ultrasound and scintigraphy (DPS+SPECT/CT) were concordant in 16/31 patients. For the rest of them, scintigraphy proved correct in 14/15, and both techniques failed in one case. There was a significant correlation between level of uptake and iPTH level, gland weight, and maximum diameter.
Early SPECT/CT improves sensitivity and the locating of parathyroid pathological glands and increases diagnostic confidence. iPTH level, glandular size, and weight are related to the qualitative assessment of Tc-MIBI uptake in early DPS.
评估锝-甲氧基异丁基异腈双时相闪烁扫描术(DPS)及早期SPECT/CT在原发性甲状旁腺功能亢进症(PHPT)患者术前评估中的价值。同时,计算摄取与一些生物学参数之间的相关性。
纳入40例PHPT患者,其中37例为单发腺瘤,1例为增生,2例为双腺瘤。15例患者存在异位腺体。所有患者均进行了DPS及早期SPECT/CT检查。40例中有31例进行了超声检查。所有患者均接受了手术、术中甲状旁腺激素(iPTH)测量及组织病理学检查。对DPS摄取进行定性评估,并与术前血钙、iPTH水平、腺体重量及最大直径进行相关性分析。
在平面显像研究中,有23例阳性病例,8例可疑病例,9例阴性病例。通过SPECT/CT,9例阴性病例中的8例被定位。所有可疑病例均被确认为阳性。16例(12例异位)患者的腺体定位得到改善。在3例多腺体疾病(MGD)患者中,DPS+SPECT/CT未能检测到单发腺瘤及至少一个腺体。以患者为单位计算的敏感性为:DPS为72.5%,DPS+SPECT/CT为90%,超声为42%。超声与闪烁扫描术(DPS+SPECT/CT)在31例患者中的16例结果一致。对于其余患者,闪烁扫描术在15例中的14例结果正确,两种技术在1例中均失败。摄取水平与iPTH水平、腺体重量及最大直径之间存在显著相关性。
早期SPECT/CT提高了甲状旁腺病变腺体的敏感性及定位,并增加了诊断信心。iPTH水平、腺体大小及重量与早期DPS中Tc-MIBI摄取的定性评估相关。